| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | 215259 | 011 | ANDA | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No | 2023/01/18 | 2023/01/18 | ASCENT PHARMS INC | Prescription |
| LEVOTHYROXINE SODIUM | 215259 | 012 | ANDA | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No | 2023/01/18 | 2023/01/18 | ASCENT PHARMS INC | Prescription |
| LEVOTHYROXINE SODIUM | 217066 | 001 | ANDA | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 100MCG/VIAL | No | No | 2023/03/24 | 2023/03/24 | ZYDUS PHARMS | Prescription |
| LEVOTHYROXINE SODIUM | 217066 | 002 | ANDA | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 200MCG/VIAL | No | No | 2023/03/24 | 2023/03/24 | ZYDUS PHARMS | Prescription |
| LEVOTHYROXINE SODIUM | 217066 | 003 | ANDA | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 500MCG/VIAL | No | No | 2023/03/24 | 2023/03/24 | ZYDUS PHARMS | Prescription |